Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae174Source: DataRank Database

High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.81)OA: hybridTopics (52)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jinyan Liu ORCID,Ai‐ris Y. Collier ORCID,Catherine Jacob-Dolan ORCID,Yasmeen Senussi ORCID,Ella Borberg ORCID

Live enrichment

PubMed:38566610 PMC:PMC11420766 OpenAlex:https://openalex.org/W4393856164

National Institutes of Health

Grant: CA260476

NIAID NIH HHS

Grant: R21 AI169309

NCI NIH HHS

Grant: U01 CA260476

National Institutes of Health

Grant: 3U01CA260476-02S2

Immunologic Signatures of SARS-CoV-2 Vaccination and Disease

Massachusetts Consortium for Pathogen Readiness

FWCI

1.81

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae174/57141792/jiae174.pdf

publisherhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae174/57141792/jiae174.pdf

publisherhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae174/57262034/jiae174.pdf

publisherhttps://academic.oup.com/jid/article-pdf/230/3/e601/59248724/jiae174.pdf

journalhttps://doi.org/10.1093/infdis/jiae174

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2Coronavirus Nucleocapsid ProteinsCOVID-19 Serological TestingAdultAgedAntibodies, ViralFemaleHumansMaleMiddle AgedSensitivity and SpecificityT-LymphocytesCytokinesNucleocapsid

Keywords

SerologyVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationCoronavirus disease 2019 (COVID-19)AntibodyImmune systemMedicineBiologyImmunologyPathologyInfectious disease (medical specialty)DiseaseInfectionImmunityNucleocapsidSars-cov-2MaleAdultBrief ReportT-LymphocytesCOVID-19Middle AgedAntibodies, ViralSensitivity and SpecificityCOVID-19 Serological TestingHumansCoronavirus Nucleocapsid ProteinsCytokinesFemaleAged

Sustainable Development Goals

SDG 0: Good health and well-being